Wearable Electromagnetic Headband Enters RCT for Treatment-Resistant Depression
A Danish double-blind RCT tests a novel at-home electromagnetic field headband against sham for moderate-to-severe depression over 8 weeks.
20 articles
A Danish double-blind RCT tests a novel at-home electromagnetic field headband against sham for moderate-to-severe depression over 8 weeks.
New research in Cell maps the fronto-insular circuits behind accelerated TMS, potentially transforming rapid depression treatment.
Non-invasive sensory stimulation reduces brain plaques by up to 53% in studies, offering new hope for Alzheimer's treatment.
AI-personalized neurostimulation tested in 67 UK teachers experiencing work-related rumination, with mixed but promising results.
A UCLA mouse study identifies the specific prefrontal neuron type responsible for TMS's fast-acting antidepressant action.
Scientists develop pathway-selective drug that activates beneficial brain receptors while avoiding negative feedback loops.
A naturally occurring fatty acid amide activates immune cells in the retina, protecting neurons and blood vessels from degenerative damage.
A randomized pilot study finds PEMF therapy significantly improved fatigue, sleep, depression, and walking capacity in post-COVID-19 patients over 5 weeks.
Scientists used stem cell-derived vesicles to deliver light-activated gene therapy to the brain without surgery, reversing cognitive decline in Alzheimer's mice.
PEMFs repair mitochondrial damage and boost brain signaling pathways in stressed neurons, offering new therapeutic hope.
A new Cell study reveals the fronto-insular circuit as the key mediator of TMS antidepressant effects, opening the door to optimized treatment.
A 4-week pilot trial finds nicotinamide riboside boosts cerebrovascular response and cognitive performance in older adults with peripheral artery disease.
Researchers identify RORA as a key driver of cataract formation by triggering oxidative damage and cell aging in the lens โ and find a small-molecule inhibitor that may reverse it.
AAV delivery of AIBP protein restores cholesterol balance, silences inflammation, and preserves vision in glaucoma models.
Editorial reviews emerging treatments including brain stimulation, psychedelics, and microbiome therapies for eating disorders.
Researchers combined ultrasound with gene therapy to treat Leigh syndrome, significantly extending survival in mouse models.
AI framework Reti-Pioneer screens for seven systemic diseases from a retinal photo, outperforming standard lab tests in speed and accuracy.
Bilateral theta burst stimulation enhanced neural repair and restored function after stroke in non-human primates through multiple mechanisms.
A year-long sham-controlled trial finds active VNS meaningfully improves daily function and quality of life in patients who failed 4+ antidepressants.
A multicenter RCT in JAMA Neurology finds electroacupuncture nearly doubles responder rates vs sham for chronic shingles nerve pain.